AIMS: To investigate the demographic, sexual, and other substance use risk correlates of amphetamine use among men in northern Thailand prior to the current epidemic of amphetamine use in the Kingdom. DESIGN: Cross-sectional quantitative behavioral questionnaires. SETTING: Thai Ministry of Health STD and HIV Anonymous Test Sites in the upper northern provinces of Chiang Mai and Lamphun. PARTICIPANTS: Adult Thai men recruited at clinics for enrollment in an HIV seroincidence cohort study (The Thai HIVNET). All men were HIV negative at enrollment, and had at least one self-reported sexual risk for HIV infection (a recent STD, use of sex workers, multiple sexual partners, low or absent condom use, sex with men). MEASUREMENTS: Participants answered a structured questionnaire. FINDINGS: Lifetime history of amphetamine use was reported by 133/914 men, 14.5%. Older age was protective for use (odds ratio (OR) 0.5) and use was associated with use of other substances; heroin (OR 7.1), thinner (OR 6.2), opium (OR 5.9), and marijuana (OR 5.7). Several STDs were associated with amphetamine use: gonorrhea (OR 2.3) and genital warts (OR 2.4), and any STD (OR 1.9). In multivariate analysis, use of heroin (OR 3.1), soft drugs (OR 4.9), and a history of gonorrhea (OR 2.0) were independently associated with amphetamine use in northern Thai men. CONCLUSIONS: Associations between young age, gonorrhea, other substance use and amphetamines indicate that prevention measures could occur at STD clinics and be incorporated into school programs when individuals are entering adolescence.
AIMS: To investigate the demographic, sexual, and other substance use risk correlates of amphetamine use among men in northern Thailand prior to the current epidemic of amphetamine use in the Kingdom. DESIGN: Cross-sectional quantitative behavioral questionnaires. SETTING: Thai Ministry of Health STD and HIV Anonymous Test Sites in the upper northern provinces of Chiang Mai and Lamphun. PARTICIPANTS: Adult Thai men recruited at clinics for enrollment in an HIV seroincidence cohort study (The Thai HIVNET). All men were HIV negative at enrollment, and had at least one self-reported sexual risk for HIV infection (a recent STD, use of sex workers, multiple sexual partners, low or absent condom use, sex with men). MEASUREMENTS: Participants answered a structured questionnaire. FINDINGS: Lifetime history of amphetamine use was reported by 133/914 men, 14.5%. Older age was protective for use (odds ratio (OR) 0.5) and use was associated with use of other substances; heroin (OR 7.1), thinner (OR 6.2), opium (OR 5.9), and marijuana (OR 5.7). Several STDs were associated with amphetamine use: gonorrhea (OR 2.3) and genital warts (OR 2.4), and any STD (OR 1.9). In multivariate analysis, use of heroin (OR 3.1), soft drugs (OR 4.9), and a history of gonorrhea (OR 2.0) were independently associated with amphetamine use in northern Thai men. CONCLUSIONS: Associations between young age, gonorrhea, other substance use and amphetamines indicate that prevention measures could occur at STD clinics and be incorporated into school programs when individuals are entering adolescence.
Authors: Christina S Meade; Melissa H Watt; Kathleen J Sikkema; Lisa X Deng; Krista W Ranby; Donald Skinner; Desiree Pieterse; Seth C Kalichmann Journal: Drug Alcohol Depend Date: 2012-06-19 Impact factor: 4.492
Authors: Marie-Claude Couture; Jennifer L Evans; Neth San Sothy; Ellen S Stein; Keo Sichan; Lisa Maher; Kimberly Page Journal: Drug Alcohol Depend Date: 2011-08-04 Impact factor: 4.492
Authors: Kimberly C Brouwer; Patricia Case; Rebeca Ramos; Carlos Magis-Rodríguez; Jesus Bucardo; Thomas L Patterson; Steffanie A Strathdee Journal: Subst Use Misuse Date: 2006 Impact factor: 2.164
Authors: Susan G Sherman; Danielle German; Bangorn Sirirojn; Nick Thompson; Apinun Aramrattana; David D Celentano Journal: J Adolesc Health Date: 2007-09-29 Impact factor: 5.012
Authors: Danielle German; Susan G Sherman; Carl A Latkin; Bangorn Sirirojn; Nicholas Thomson; Catherine G Sutcliffe; Apinun Aramrattana; David D Celentano Journal: Int J Drug Policy Date: 2008-01-11
Authors: Lauren E DiMiceli; Susan G Sherman; Apinun Aramrattana; Bangorn Sirirojn; David D Celentano Journal: BMC Public Health Date: 2016-02-19 Impact factor: 3.295